Structure-Guided Design of Antibodies
Justin A Caravella, Deping Wang, Scott M Glaser
1Physical Biochemistry, Drug Discovery, Biogen Idec Inc., 14 Cambridge Center, Cambridge, MA 02142, USA. alexey.lugovskoy@biogenidec.com.
Current Computer-Aided Drug Design
|February 5, 2016
Summary
Structure-guided computational methods enhance antibody design for improved antigen binding and stability. This review highlights recent successes in engineering antibodies and antibody-like molecules with optimized affinity and specificity.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Monoclonal antibodies are key biological agents with high affinity and specificity for antigens.
- Hybridoma technology (1975) and advances in recombinant DNA, computational, and biophysical methods have deepened understanding of antibody sequence-structure-function relationships.
Purpose of the Study:
- To review recent successes in structure-guided computational methods for antibody design.
- To focus on optimizing antibody affinity, specificity, and protein stability.
Main Methods:
- Utilizing structure-guided computational approaches.
- Manipulating antibody sequences through recombinant DNA technologies.
- Applying biophysical methods to understand antibody properties.
Main Results:
- Successful design of antibodies and antibody-like molecules with enhanced properties.
- Demonstrated optimization of antigen affinity and specificity.
- Achieved improved protein stability in engineered antibodies.
Conclusions:
- Structure-guided computational design is a powerful strategy for engineering antibodies.
- These methods enable the creation of novel antibodies with tailored biological and biophysical characteristics.
- Continued advancements promise further optimization of antibody therapeutics and research tools.
Related Concept Videos
Antibody Structure
67.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
67.3K
Antibody Structure
15.1K
15.1K
Antibody Structure and Classes
10.2K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
10.2K
Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K


